155 related articles for article (PubMed ID: 35146812)
1. In vivo electrophysiological study of the targeting of 5-HT
Schweimer JV; Brouard JT; Li Y; Sánchez C; Sharp T
Eur J Neurosci; 2022 Mar; 55(6):1409-1423. PubMed ID: 35146812
[TBL] [Abstract][Full Text] [Related]
2. Involvement of 5-HT3 receptors in the action of vortioxetine in rat brain: Focus on glutamatergic and GABAergic neurotransmission.
Riga MS; Sánchez C; Celada P; Artigas F
Neuropharmacology; 2016 Sep; 108():73-81. PubMed ID: 27106166
[TBL] [Abstract][Full Text] [Related]
3. The multimodal antidepressant vortioxetine may facilitate pyramidal cell firing by inhibition of 5-HT
Dale E; Grunnet M; Pehrson AL; Frederiksen K; Larsen PH; Nielsen J; Stensbøl TB; Ebert B; Yin H; Lu D; Liu H; Jensen TN; Yang CR; Sanchez C
Brain Res; 2018 Jun; 1689():1-11. PubMed ID: 29274875
[TBL] [Abstract][Full Text] [Related]
4. Differentiated effects of the multimodal antidepressant vortioxetine on sleep architecture: Part 2, pharmacological interactions in rodents suggest a role of serotonin-3 receptor antagonism.
Leiser SC; Iglesias-Bregna D; Westrich L; Pehrson AL; Sanchez C
J Psychopharmacol; 2015 Oct; 29(10):1092-105. PubMed ID: 26174134
[TBL] [Abstract][Full Text] [Related]
5. The rapid recovery of 5-HT cell firing induced by the antidepressant vortioxetine involves 5-HT(3) receptor antagonism.
Bétry C; Pehrson AL; Etiévant A; Ebert B; Sánchez C; Haddjeri N
Int J Neuropsychopharmacol; 2013 Jun; 16(5):1115-27. PubMed ID: 23089374
[TBL] [Abstract][Full Text] [Related]
6. Regional distribution of serotonergic receptors: a systems neuroscience perspective on the downstream effects of the multimodal-acting antidepressant vortioxetine on excitatory and inhibitory neurotransmission.
Pehrson AL; Jeyarajah T; Sanchez C
CNS Spectr; 2016 Apr; 21(2):162-83. PubMed ID: 26250622
[TBL] [Abstract][Full Text] [Related]
7. Multimodal antidepressant vortioxetine increases frontal cortical oscillations unlike escitalopram and duloxetine--a quantitative EEG study in rats.
Leiser SC; Pehrson AL; Robichaud PJ; Sanchez C
Br J Pharmacol; 2014 Sep; 171(18):4255-72. PubMed ID: 24846338
[TBL] [Abstract][Full Text] [Related]
8. Effect of the multimodal acting antidepressant vortioxetine on rat hippocampal plasticity and recognition memory.
Bétry C; Etiévant A; Pehrson A; Sánchez C; Haddjeri N
Prog Neuropsychopharmacol Biol Psychiatry; 2015 Apr; 58():38-46. PubMed ID: 25524057
[TBL] [Abstract][Full Text] [Related]
9. Subchronic vortioxetine treatment -but not escitalopram- enhances pyramidal neuron activity in the rat prefrontal cortex.
Riga MS; Teruel-Martí V; Sánchez C; Celada P; Artigas F
Neuropharmacology; 2017 Feb; 113(Pt A):148-155. PubMed ID: 27671324
[TBL] [Abstract][Full Text] [Related]
10. Vortioxetine Subchronically Activates Serotonergic Transmission via Desensitization of Serotonin 5-HT
Okada M; Okubo R; Fukuyama K
Int J Mol Sci; 2019 Dec; 20(24):. PubMed ID: 31835640
[TBL] [Abstract][Full Text] [Related]
11. Vortioxetine dose-dependently reverses 5-HT depletion-induced deficits in spatial working and object recognition memory: a potential role for 5-HT1A receptor agonism and 5-HT3 receptor antagonism.
du Jardin KG; Jensen JB; Sanchez C; Pehrson AL
Eur Neuropsychopharmacol; 2014 Jan; 24(1):160-71. PubMed ID: 23916504
[TBL] [Abstract][Full Text] [Related]
12. Vortioxetine disinhibits pyramidal cell function and enhances synaptic plasticity in the rat hippocampus.
Dale E; Zhang H; Leiser SC; Xiao Y; Lu D; Yang CR; Plath N; Sanchez C
J Psychopharmacol; 2014 Oct; 28(10):891-902. PubMed ID: 25122043
[TBL] [Abstract][Full Text] [Related]
13. Sub-chronic vortioxetine (but not escitalopram) normalizes brain rhythm alterations and memory deficits induced by serotonin depletion in rats.
Riga MS; Sanchez C; Celada P; Artigas F
Neuropharmacology; 2020 Nov; 178():108238. PubMed ID: 32750446
[TBL] [Abstract][Full Text] [Related]
14. Vortioxetine, a novel antidepressant with multimodal activity: review of preclinical and clinical data.
Sanchez C; Asin KE; Artigas F
Pharmacol Ther; 2015 Jan; 145():43-57. PubMed ID: 25016186
[TBL] [Abstract][Full Text] [Related]
15. Effects of acute and sustained administration of vortioxetine on the serotonin system in the hippocampus: electrophysiological studies in the rat brain.
El Mansari M; Lecours M; Blier P
Psychopharmacology (Berl); 2015 Jul; 232(13):2343-52. PubMed ID: 25665528
[TBL] [Abstract][Full Text] [Related]
16. The 5-HT
Skovgård K; Agerskov C; Kohlmeier KA; Herrik KF
Neuropharmacology; 2018 Dec; 143():130-142. PubMed ID: 30243914
[TBL] [Abstract][Full Text] [Related]
17. Modes and nodes explain the mechanism of action of vortioxetine, a multimodal agent (MMA): blocking 5HT3 receptors enhances release of serotonin, norepinephrine, and acetylcholine.
Stahl SM
CNS Spectr; 2015 Oct; 20(5):455-9. PubMed ID: 26122791
[TBL] [Abstract][Full Text] [Related]
18. A 5-HT3 receptor antagonist potentiates the behavioral, neurochemical and electrophysiological actions of an SSRI antidepressant.
Bétry C; Overstreet D; Haddjeri N; Pehrson AL; Bundgaard C; Sanchez C; Mørk A
Pharmacol Biochem Behav; 2015 Apr; 131():136-42. PubMed ID: 25697477
[TBL] [Abstract][Full Text] [Related]
19. Impact of Vortioxetine on Synaptic Integration in Prefrontal-Subcortical Circuits: Comparisons with Escitalopram.
Chakroborty S; Geisbush TR; Dale E; Pehrson AL; Sánchez C; West AR
Front Pharmacol; 2017; 8():764. PubMed ID: 29123483
[TBL] [Abstract][Full Text] [Related]
20. Vortioxetine (Lu AA21004), a novel multimodal antidepressant, enhances memory in rats.
Mørk A; Montezinho LP; Miller S; Trippodi-Murphy C; Plath N; Li Y; Gulinello M; Sanchez C
Pharmacol Biochem Behav; 2013 Apr; 105():41-50. PubMed ID: 23380522
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
